Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Short term Debt (2016 - 2017)

Historic Short term Debt for Bone Biologics (BBLG) over the last 2 years, with Q3 2017 value amounting to $12.9 million.

  • Bone Biologics' Short term Debt rose 4333.33% to $12.9 million in Q3 2017 from the same period last year, while for Sep 2017 it was $12.9 million, marking a year-over-year increase of 4333.33%. This contributed to the annual value of $1.2 million for FY2016, which is N/A changed from last year.
  • Latest data reveals that Bone Biologics reported Short term Debt of $12.9 million as of Q3 2017, which was up 4333.33% from $12.2 million recorded in Q2 2017.
  • Bone Biologics' Short term Debt's 5-year high stood at $12.9 million during Q3 2017, with a 5-year trough of $1.2 million in Q4 2016.